Juvenile Localized Scleroderma. Questions of Treatment [PDF]
Вопросы современной педиатрии, 2020 Juvenile localized scleroderma (JLS) is a group of childhood diseases with the main symptom — skin and subcutaneous structures lesions, without any organ involvement. There is active (inflammatory) and fibrotic phase in development of JLS.
Rinat K. Raupov, Mikhail M. Kostik
doaj +11 more sources
Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics [PDF]
Вопросы современной педиатрии, 2020 The localized scleroderma (morphea) is the clinical option of the juvenile scleroderma, the third in prevalence rheumatic condition in pediatrics. The article summarizes all the data on the classification, diagnostics, and differential diagnosis of ...
Rinat K. Raupov +2 more
doaj +2 more sources
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives [PDF]
Pediatric Rheumatology Online Journal, 2023 Background Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permanent damage and worse outcomes.
Leigh A. Stubbs +20 more
doaj +2 more sources
Reliability of using an ultrasound scoring measure for juvenile localized scleroderma (jLS) [PDF]
Pediatric Rheumatology Online Journal, 2012 Li Suzanne C +13 more
doaj +2 more sources
Localized scleroderma in children
Przegląd Dermatologiczny, 2020 Localized scleroderma is an autoimmune disease affecting the dermis and underlying tissues (subcutaneous tissue, fascia, muscles, bones). The disease mainly occurs in women aged 20–50 years; however, children aged 7–10 years represent about 15% of all ...
Katarzyna A. Wolska-Gawron +1 more
doaj +1 more source
Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies [PDF]
Pediatric Rheumatology Online Journal, 2012 Li Suzanne C +12 more
doaj +2 more sources
Zdorovʹe Rebenka, 2019 Among rheumatic diseases in children, a special place belongs to juvenile localized scleroderma, which is highlighted as a separate form in the structure of scleroderma diseases and is characterized by: the onset of the disease up to 16 years, skin ...
L.F. Bogmat, V.V. Nikonova
doaj +1 more source
Research Progress on Pathogenesis and Treatment of Juvenile Localized Scleroderma
Xiehe Yixue Zazhi, 2022 Juvenile localized scleroderma (JLS) is a rare autoimmune disease in children. The lack of specificity in the early symptoms of JLS makes it easy to be misdiagnosed and missed, which leads to the continuous progression of the lesions, and even causes ...
YANG Jingyi, XU Qianyue, YU Hong
doaj +1 more source
Efficacy and safety of methotrexate treatment of juvenile localized scleroderma [PDF]
Pediatric Rheumatology Online Journal, 2008 Osminina MK +4 more
doaj +2 more sources
Ultrasonography, MRI and classic radiography of skin and MSK involvement in juvenile scleroderma
Journal of Ultrasonography, 2020 Scleroderma is a rare, autoimmune, chronic condition that affects the connective tissue by excessive collagen production. If diagnosed before the age of 16, it is referred to as juvenile scleroderma.
Idzior Marta +4 more
doaj +1 more source